Skinvisible (SKVI) Other Operating Expenses (2010 - 2026)
Skinvisible's (SKVI) quarterly Other Operating Expenses came in at $4996.0 in Q2 2026, down 1.32% year-over-year from $5063.0 in Q2 2025, and little changed quarter-over-quarter from $5007.0 in Q1 2026.
Analysis
Skinvisible (SKVI) Other Operating Expenses (2010 - 2026) Analysis & Trends
Skinvisible has disclosed Other Operating Expenses across 17 years of filings, most recently posting $4996.0 for Q2 2026.
- In Q2 2026, Other Operating Expenses fell 1.32% year-over-year to $4996.0; the TTM figure through Jun 2026 stood at $20239.0 (down 3.58% YoY), while the FY2025 annual figure was $20239.0, down 0.97% from the prior year.
- Other Operating Expenses came in at $4996.0 for Q2 2026 at Skinvisible, roughly flat from $5007.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $5937.0 in Q3 2024 to a low of $4540.0 in Q3 2023.
- Average Other Operating Expenses over 5 years is $4899.4, with a median of $4798.0 recorded in 2023.
- Year-over-year, Other Operating Expenses soared 30.77% in 2024 and slipped 13.79% in 2025.
- Over 5 years, Other Operating Expenses stood at $4738.0 in 2022, then grew by 0.19% to $4747.0 in 2023, then advanced by 6.38% to $5050.0 in 2024, then advanced by 1.35% to $5118.0 in 2025, then decreased by 2.38% to $4996.0 in 2026.
- Per Business Quant data, the three most recent Other Operating Expenses figures were $4996.0 in Q2 2026, $5007.0 in Q1 2026, and $5118.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 647.06 Bn | 626.30 Bn | 17.26 Bn |
| 2 | AbbVie | 440.06 Bn | 433.49 Bn | 12.70 Bn |
| 3 | Merck | 364.19 Bn | 357.05 Bn | 12.21 Bn |
| 4 | Novartis Ag | 268.45 Bn | 260.76 Bn | 11.24 Bn |
| 5 | Pfizer | 158.40 Bn | 146.70 Bn | 10.94 Bn |
| 6 | Sanofi | 52.57 Bn | 45.19 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.32 Bn | 44.32 Bn | - |
| 8 | Incyte | 24.98 Bn | 20.44 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.15 Bn | 18.49 Bn | 683.80 Mn |
| 10 | Skinvisible | 1.08 Mn | 1.08 Mn | 5,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4,996.00 |
| Mar 31, 2026 | 5,007.00 |
| Dec 31, 2025 | 5,118.00 |
| Sep 30, 2025 | 5,118.00 |
| Jun 30, 2025 | 5,063.00 |
| Mar 31, 2025 | 4,940.00 |
| Dec 31, 2024 | 5,050.00 |
| Sep 30, 2024 | 5,937.00 |
| Jun 30, 2024 | 4,756.00 |
| Mar 31, 2024 | 4,695.00 |
| Dec 31, 2023 | 4,747.00 |
| Sep 30, 2023 | 4,540.00 |
| Jun 30, 2023 | 4,840.00 |
| Mar 31, 2023 | 4,644.00 |
| Dec 31, 2022 | 4,738.00 |
| Sep 30, 2022 | 4,729.00 |
| Jun 30, 2022 | 4,678.00 |
| Mar 31, 2022 | 4,593.00 |
| Dec 31, 2021 | 4,695.00 |
| Sep 30, 2021 | 4,696.00 |